BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study Biotech Investing
Beam Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates Life Science Investing
Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 Life Science Investing
Foghorn Therapeutics Provides First Quarter 2026 Financial and Corporate Update Life Science Investing
Monte Rosa Therapeutics Announces First Quarter 2026 Financial Results and Business Updates Life Science Investing
Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates Life Science Investing
Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update Life Science Investing
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights Life Science Investing
InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update Pharmaceutical Investing
